Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10048171HBVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30004651HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30004652HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30002798HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30007200HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30007201HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30007202HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30075419HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30075420HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30075421HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TCGA Plot Options
Drug Information
GenePRKCA
DrugBank IDDB06451
Drug NameAprinocarsen
Target IDBE0001132
UniProt IDP17252
Regulation Type
PubMed IDs16424642; 15868384
CitationsLahn M, Sundell K, Kohler G: The role of protein kinase C-alpha in hematologic malignancies. Acta Haematol. 2006;115(1-2):1-8.@@Vansteenkiste J, Canon JL, Riska H, Pirker R, Peterson P, John W, Mali P, Lahn M: Randomized phase II evaluation of aprinocarsen in combination with gemcitabine and cisplatin for patients with advanced/metastatic non-small cell lung cancer. Invest New Drugs. 2005 Jun;23(3):263-9.
GroupsInvestigational
Direct Classification
SMILES
Pathways
PharmGKB
ChEMBL